Search results
Results from the WOW.Com Content Network
The myxoma virus causes only a mild disease in these species, with signs limited to the formation of skin nodules. [3] Myxomatosis is the name of the severe and often fatal disease in European rabbits caused by the myxoma virus. Different strains exist which vary in their virulence.
Myxomatosis is the name of the lethal disseminated disease that occurs when European rabbits (Oryctolagus cuniculus) are infected with myxoma virus; both the South and North American types are capable of causing this disease. Californian myxoma virus is particularly virulent, causing 100% mortality. [3]
In the United States, the National Notifiable Disease Surveillance System (NNDSS) is responsible for sharing information regarding notifiable diseases. As of 2020, the following are the notifiable diseases in the US as mandated by the Centers for Disease Control and Prevention: [1]
The new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will there be a summer surge? Experts discuss transmission, symptoms, and vaccines.
Hansen's disease (Leprosy) Leptospirosis: Leptospirosis: Listeriosis: Listeriosis: Listeriosis: Lyme disease: Meningococcal disease: Meningococcal infection (invasive) Meningitis : pyogenic and non-pyogenic Meningococcal septicaemia/ Acute Meningitis: Meningococcal disease: MRSA: Community-associated methicillin-resistant Staphylococcus aureus ...
Most Americans now have some immunity against the virus, either by vaccination, infection or both. But there have been some rare cases in which certain unvaccinated people seem to have been able ...
The spotty skin pigmentation and lentigines occur most commonly on the face, especially on the lips, eyelids, conjunctiva and oral mucosa. [3] Cardiac myxomas may lead to embolic strokes and heart failure [4] and may present with fever, joint pain, shortness of breath, diastolic rumble and tumor plop.
JN.1 is a COVID-19 variant that descended from BA.2.86, explains infectious disease expert Amesh Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security. JN.1 is “another ...